Safety of Therapeutic Oligonucleotides
May 13, 2020
Patrik Andersson, Principal Scientist and RNA Therapeutics Safety Lead, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gothenburg…
Circular RNA Immunity
March 25, 2020
Grace Chen (Yale School of Medicine), 8 am PDT/11 am EDT/3 pm GMT/4 pm CET/8.30 pm IST/11 pm CST/March 26 12 am JST/2 am AEDT…
Antisense Oligonucleotides- Mechanisms of Action and Rational Design
February 26, 2020
Robert MacLeod (Ionis Pharmaceuticals), 8:00 PST/11:00 EST/16.00 GMT/17:00 CET/21.30 IST/February 27 0:00 CST/1:00 JST/2:00 AEDT…
Delivery of Macromolecular Therapeutics: Tackling a Billion Year Old Barrier
December 17, 2019
All macromolecular therapeutics, including ASOs, siRNAs, peptides, proteins, CRISPR, mRNA and non-viral DNA vectors, are taken up into…